Follow us:

Strong full-year performance

With an organic growth of 14% in the financial year 2010/11 Chr. Hansen meets its expectations to the organic revenue growth for the year.

"During the year the global economy has been through turbulent times with significant uncertainty. With such global turmoil we are pleased that Chr. Hansen once again can report a strong performance. We delivered on our financial targets for the year with profitable growth across all business areas resulting in organic growth of 14%. Excluding the effect of carmine prices, organic growth reached 10%. The positive development is a clear evidence of the resilience and scalability of our business model," says CEO Lars Frederiksen.

"We continue on track to meet our long term growth expectations and expect organic growth in 2011/12 to reach 7-10% excluding the effect of carmine prices. We expect carmine prices to decline in the coming year affecting the organic growth negatively by approximately two percentage points to 5-8%. EBIT margin before special items is expected to be above 26%.

Revenue growth continues to be driven by increased demand for healthy food products not least from the growing middle income population in emerging markets and conversion from in-house bulk starter to industrialized produced cultures and from synthetic to natural colors," says Lars Frederiksen.


  • Revenue in 2010/11 amounted to EUR 636 million, up 15% compared to financial year 2009/10
  • Organic revenue growth of 14%
  • EBIT before special items up by 14% to EUR 159 million
  • In Q4 2010/11 revenue increased by 5% compared to Q4 2009/10, corresponding to an organic revenue growth of 9%
  • EBIT before special items reached 28% in Q4

Please see the annual report for further details.

Related news:
For further information please contact:
Helle Rexen
Communications Consultant

About us

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Related news

Strong half-year performance
Strong half-year performance
With organic growth of 11% in the first half of financial year 2011/12 Chr. Hansen continues to show solid performance. Initiating a share buy-back program, Chr. Hansen distributes excess capital to its shareholders.
Solid first quarter performance
Solid first quarter performance
With organic growth of 13% in the first three months of financial year 2011/12 Chr. Hansen continues its profitable journey.

Contact our press team

Klara Halkjaer
Head of media relations, Corporate Communications
Denmark, Hoersholm, headquarters
Phone:+45 53 39 23 62
Send e-mail
Helle Rexen
Communications Consultant
Denmark, Hoersholm, headquarters
Corporate Communications
Phone:+45 45 74 76 36
Mobile: +45 2074 2840
Send e-mail

Subscribe to our mail service
And get the latest press releases delivered by email.

Follow Chr. Hansen on Twitter
for the latest press releases, company announcements and job announcements

Follow our news feeds
We also provide a news feed you can subscribe to via RSS

Latest news

New CFO appointed
Søren Westh Lonning has been appointed the new Chief...
Encouraging performance in the first nine months
Chr. Hansen realizes strong organic growth of 9% in the...
Chr. Hansen develops game-changing fermentation process for carmine
In collaboration with University of Copenhagen, Department...
More news